Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Achillion
Achillion
5 Drugs That Investors May Be Undervaluing
Motley Fool
Mon, 07/13/15 - 11:04 am
Amicus Therapeutics
Galafold
Receptos
ozanimod
GS-5816
Gilead Sciences
ACH-3102
Achillion
Ophthotech
Fovista
Will the J&J Deal With Achillion Transform the Hep C Market?
WSJ Pharmalot
Thu, 05/21/15 - 09:50 am
JNJ
hepatitis C
Achillion
Achillion partners with J&J to develop hep C drugs
Yahoo/Reuters
Tue, 05/19/15 - 06:23 pm
Achillion
JNJ
R&D
hepatitis C
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
TheStreet.com
Tue, 05/19/15 - 09:50 am
M&A
social media
twitter
Gilead Sciences
hepatitis C
Achillion
Achillion Pharmaceuticals reports first-quarter loss but tops expectations
Yahoo/AP
Thu, 05/7/15 - 10:55 am
Achillion
earnings
Gilead Will Keep Hepatitis C Dominance In Its Grip With Recent Trial Results
Seeking Alpha
Tue, 04/28/15 - 08:49 am
Gilead Sciences
Harvoni
hepatitis C
AbbVie
Bristol-Myers Squibb
Merck
Achillion
Should Gilead Sciences, Inc. Be Worried By Achillion Pharmaceuticals?
Motley Fool
Wed, 04/1/15 - 08:45 am
Gilead Sciences
Achillion
hepatitis C
Sovaldi
Harvoni
[video]2 Small Biotech Stocks Dreaming Big in Hepatitis C
Motley Fool
Mon, 02/16/15 - 10:15 am
hepatitis C
Regulus
Achillion
Achillion HCV-1 regimen achieves 100% SVR12 at six weeks
Seeking Alpha
Mon, 02/9/15 - 08:26 am
Achillion
hepatitis C
ACH-3102
Gilead Sciences
Sovaldi
The Best-Performing Biotechnology Stocks Of 2014
Forbes
Thu, 01/1/15 - 02:32 pm
biotech
Avanir
OvaScience
Agios
Bluebird Bio
Receptos
Prosensa
Pernix
Achillion
Amicus Therapeutics
CytoSorbents
PTC Therapeutics
Achillion Pharma Takeout Less Likely Following Subpar Hep C Drug Results
TheStreet.com
Mon, 12/22/14 - 01:14 pm
Achillion
ACH-3422
hepatitis C
M&A
Why Gilead Sciences and AbbVie Care About This Tiny Company
Motley Fool
Thu, 12/11/14 - 10:32 am
AbbVie
Gilead Sciences
Achillion
hepatitis C
These 4 Biotech Stocks Have Been On Fire
Yahoo/Benzinga
Mon, 12/8/14 - 11:12 pm
Agios Pharmaceuticals
Achillion
Amicus Therapeutics
Orexigen
2 Skyrocketing Biotech Stocks In A Stalling Market
Yahoo/Benzinga
Mon, 11/17/14 - 04:40 pm
Orexigen
Achillion
4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic
24/7 Wall St
Thu, 11/13/14 - 09:34 am
hepatitis C
AbbVie
Achillion
Gilead Sciences
Merck
Achillion Pharmaceuticals (ACHN): A Potential Acquisition Target For Gilead Sciences (GILD)
Bidness Etc.
Tue, 11/11/14 - 10:32 am
Achillion
M&A
Gilead Sciences
hepatitis C
Achillion Pharma rises on results from study combining hepatitis C drugs ACH-3102 and Sovaldi
Yahoo/AP
Mon, 11/10/14 - 03:55 pm
Achillion
ACH-3102
hepatitis C
Sovaldi
Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD)
Yahoo/Globe NewsWire
Sat, 11/8/14 - 10:39 am
Achillion
ACH-3102
ACH-3422
HCV
hepatitis C
Biotech stocks to watch ahead of liver disease conference
CNBC
Fri, 11/7/14 - 03:54 pm
liver disease
Gilead Sciences
Intercept Pharma
Genfit
Merck
Achillion
AbbVie
NASH
hepatitis B
hepatitis C
Gilead Sciences: Here Comes the Competition
Barron's
Tue, 10/7/14 - 01:21 pm
Gilead Sciences
hepatitis C
Sovaldi
Merck
AbbVie
Idenix
Bristol-Myers Squibb
Achillion
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »